# A Study of Ponsegromab in People With Heart Failure

Study · id `cardio:ct-nct05492500` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05492500](<https://clinicaltrials.gov/study/NCT05492500>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05492500

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 455 participants.

## Technical summary

Registry record NCT05492500. Randomized; quadruple masking; primary purpose supportive care. Start 2022-09-26 (actual); primary completion 2025-03-05 (actual). Results posted on 2026-03-18.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose supportive care
- Phase: Phase 2
- Enrolled: 455 participants (enrolled count; ClinicalTrials.gov record NCT05492500, source copy `cardio:ctgov-nct05492500-2026-03-18`, retrieved 2026-10-26)
- Started: 2022-09-26 (actual) (ClinicalTrials.gov record NCT05492500, source copy `cardio:ctgov-nct05492500-2026-03-18`, retrieved 2026-10-26)
- Primary completion: 2025-03-05 (actual) (ClinicalTrials.gov record NCT05492500, source copy `cardio:ctgov-nct05492500-2026-03-18`, retrieved 2026-10-26)
- Completion: 2025-03-05 (actual) (ClinicalTrials.gov record NCT05492500, source copy `cardio:ctgov-nct05492500-2026-03-18`, retrieved 2026-10-26)
- Results first posted: 2026-03-18 (ClinicalTrials.gov record NCT05492500, source copy `cardio:ctgov-nct05492500-2026-03-18`, retrieved 2026-10-26)
- Countries: United States; Australia; Canada; China; Czechia; Germany; Hungary; Japan; Poland; Spain; United Kingdom (ClinicalTrials.gov record NCT05492500, source copy `cardio:ctgov-nct05492500-2026-03-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05492500-2026-03-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study of Ponsegromab in People With Heart Failure
- Acronym: GARDEN TIMI 74
- Condition: Heart Failure
- Intervention (Drug): Main cohort (Cohort A): Ponsegromab low dose
- Intervention (Drug): Main cohort (Cohort A): Ponsegromab medium dose
- Intervention (Drug): Main cohort (Cohort A): ponsegromab high dose
- Intervention (Other): Main cohort (Cohort A): Matched placebo
- Intervention (Drug): Open-label, PK Cohort (Cohort B): ponsegromab low dose
- Intervention (Drug): Open-label, PK Cohort (Cohort B): ponsegromab medium dose
- Intervention (Drug): Open-label, PK Cohort (Cohort B): ponsegromab high dose
- Intervention (Drug): Optional Cohort C: Ponsegromab low dose
- Intervention (Other): Optional Cohort C: Matched placebo
- Intervention (Drug): Optional Cohort D: Ponsegromab high dose
- Intervention (Other): Optional Cohort D: Matched placebo
- Lead sponsor: Pfizer
- Lead sponsor class: INDUSTRY
- Collaborator: The TIMI Study Group
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Pfizer (`cardio:org-pfizer`)
- Registry lists this organization as a collaborator: The TIMI Study Group (`cardio:org-the-timi-study-group`)

## Provenance

Content hash: 21421ccb08b303eb3ff400b39dc4d762d03f6ed4008036d470c672fb7ebf7604
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
